Case Study

Hunt for miRNA Signatures in Cancer - A Case Study of Sequencing and Bioinformatics

About the Case Study

Sequencing technology has evolved as a pivotal tool in life science research, offering a wealth of information. This case study delves into the use of sequencing and bioinformatics to identify miRNA signatures in pancreatic ductal adenocarcinoma (PDAC) patients, specifically focusing on the risk of lymph node metastasis.

Researchers utilized data and tumor samples from three independent cohorts, employing a comprehensive biomarker discovery and validation approach. The study successfully identified a novel miRNA signature capable of robustly recognizing lymph node metastasis (LNM) in PDAC patients.

CD Genomics is a leading service provider specializing in sequencing and bioinformatics analysis. Our services ensure accuracy and supreme data quality, leveraging cutting-edge platforms. The bioinformatics analysis platform offers novel solutions for data-driven innovation, unveiling hidden potential in biological data and providing insights for life science research.

For more information about our services:

Small RNA Analysis

Download the Case Study

* Name:

* Email Address:

* Verification code:

CD Genomics needs the contact information you provide to us in order to contact you about our products and services and other content that may be of interest to you.

By clicking below, you consent to the storage and processing of the personal information submitted above by CD Genomcis to provide the content you have requested.

* I agree to receive communications from CD Genomics.

* Tick to confirm.

For any other type of support, feel free to contact us
|